3-Chlorobenzo[b]thiophene-2-carboxylic Acid>98.0%(GC)(T)1g

4-(5-amino-1,3,4-oxadiazol-2-yl)phenol, 95.0%, 1g

Azelaic Acid>98.0%(GC)(T)250g

tert-Butyl (3,3-dimethylpiperidin-4-yl)carbamate, 95.0%, 1g

(S)-3-Amino-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 5g

tert-butyl (3R,4R)-3-amino-4-(hydroxymethyl)pyrrolidine-1-carboxylate, 97.0%, 1g

Silver(II) fluoride, 99.0%, 5g

1-Benzyl-3-carboethoxy-4-piperidone, 95.0%, 250mg

Solution d'indicateur Tashiro, dans l'éthanol, 250 ml, emballage plastique.

(R)-2-Methylpyrrolidine, 95.0%, 5g

7-bromo-1H,2H,3H,4H-thieno[3,2-d]pyrimidine-2,4-dione, 95%, 5g

6-Iodo-7-nitro-3 H -isobenzofuran-1-one, 98%, 1g

8-Bromo-2,3,4,5-tetrahydro-1H-benzo[b]azepine, 95.0%, 10g